Indications
- Prevention of vascular ischemic events in patients with symptomatic atherosclerosis
- Acute coronary syndrome without ST-segment elevation (NSTEMI)
- ST elevation MI (STEMI)
- prevention of thrombosis after placement of intracoronary stent
Administration/Absorption- oral
- Absorption is at least 50%
DistributionMechanismExcretion- elimination half-life of about eight hours
Side effectsInteractions
Contraindications
|
|
